Pharmaceutical composition containing two active ingredients for smoking cessation
US6582737B2 · kind B2 · utility
10Cited by
5References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 25, 2001 |
| Grant date | Jun 24, 2003 |
| Priority date | — |
| Expiry date | Sep 25, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A kit to alleviate tobacco-smoking withdrawal symptoms in a patient is disclosed which comprises:(a) a therapeutically effective amount of nicotine, at least one active nicotine metabolite, a combination of nicotine and an active nicotine metabolite, or an azapirone, or a pharmaceutically acceptable salt thereof;(b) a transdermal delivery system consisting essentially of a bupropion base in a therapeutically effective amount; and(c) a packaging material surrounding (a) and (b).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.